
Chris Ryan
Editorial Director at The Ringer
Podcast Co-Host at The Watch
Editorial Director, @ringer; co-host @TheWatchPod (Subscribe: https://t.co/gVFoPdvd5R), @TheRewatchables, Music Exists, @RingerNBA
Articles
-
2 weeks ago |
onclive.com | Chris Ryan
With the 2025 ASCO Annual Meeting inching closer, OncLive® tapped into leading voices in the field of hematologic oncology and asked them to detail the abstracts and emerging data they are most excited to see presented during the meeting.
-
3 weeks ago |
targetedonc.com | Chris Ryan
Findings from the phase 2/3 REFRαME-O1 trial (NCT05870748) evaluating the antibody-drug conjugate (ADC) luveltamab tazevibulin demonstrated encouraging responses, particularly in patients with ovarian cancer with low to medium FRα expression. The therapy also delivered a manageable safety profile, offering hope for a patient population with limited treatment options.
-
4 weeks ago |
chrisryan.substack.com | Chris Ryan
“What’s Up, Doctopher?” is a free occasional newsletter. To gain access to bonus content including BROMAs, TOMAs, travel updates, AMAs, What Makes this Book Great?, the DJCPR series, and a monthly open thread where you can interact with the Tangentially Speaking community, please consider becoming a paid subscriber for $5/month or $50/year — less than a buck a week! (This month’s discussion is a great one: What have you been wrong about recently?) If you’ve already subscribed, much obliged.
-
2 months ago |
chrisryan.substack.com | Chris Ryan
This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts
-
2 months ago |
chrisryan.substack.com | Chris Ryan
“What’s Up, Doctopher?” is a free occasional newsletter.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 162K
- Tweets
- 8K
- DMs Open
- No